Grifols (GRFS) EBIT (QoQ) (2010 - 2020)
Grifols (GRFS) EBIT (QoQ) (2010 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.50 Bn | 631.74 Bn | 17.26 Bn |
| 2 | AbbVie | 469.68 Bn | 463.11 Bn | 12.70 Bn |
| 3 | Merck | 375.54 Bn | 368.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.20 Bn | 295.51 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.76 Bn | 252.86 Bn | 12.86 Bn |
| 6 | Amgen | 236.70 Bn | 222.71 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.32 Bn | 179.14 Bn | 6.22 Bn |
| 8 | Pfizer | 159.56 Bn | 147.86 Bn | 10.94 Bn |
| 9 | Gsk | 106.15 Bn | 101.98 Bn | 8.24 Bn |
| 10 | Grifols | 5.44 Bn | 4.44 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -65.50% |
| Mar 31, 2019 | 271.55% |
| Jun 30, 2018 | 3.93% |
| Mar 31, 2018 | -68.20% |
| Jun 30, 2017 | 16.45% |
| Mar 31, 2017 | -44.92% |
| Dec 31, 2016 | 82.87% |
| Sep 30, 2016 | 3.88% |
| Jun 30, 2016 | 0.77% |
| Mar 31, 2016 | -67.55% |
| Dec 31, 2015 | 186.09% |
| Sep 30, 2015 | 6.23% |
| Jun 30, 2015 | -3.04% |
| Mar 31, 2015 | -75.08% |
| Dec 31, 2014 | 277.60% |
| Sep 30, 2014 | -99.95% |
| Jun 30, 2014 | 182,633.36% |
| Mar 31, 2014 | 32.85% |
| Dec 31, 2013 | -6.32% |
| Sep 30, 2013 | -2.15% |